Cite
Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database.
MLA
Oura, Mitsuaki, et al. “Fluoropyrimidine Usage in Cases with Hyperammonemia: Real-World Data Study Using the Japanese Adverse Drug Event Report (JADER) Database.” Cancer Chemotherapy & Pharmacology, vol. 92, no. 1, July 2023, pp. 7–14. EBSCOhost, https://doi.org/10.1007/s00280-023-04542-7.
APA
Oura, M., Oguro, F., Agatsuma, N., Imamaki, H., & Nishikawa, Y. (2023). Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database. Cancer Chemotherapy & Pharmacology, 92(1), 7–14. https://doi.org/10.1007/s00280-023-04542-7
Chicago
Oura, Mitsuaki, Fumiya Oguro, Nobukazu Agatsuma, Hirotaka Imamaki, and Yoshitaka Nishikawa. 2023. “Fluoropyrimidine Usage in Cases with Hyperammonemia: Real-World Data Study Using the Japanese Adverse Drug Event Report (JADER) Database.” Cancer Chemotherapy & Pharmacology 92 (1): 7–14. doi:10.1007/s00280-023-04542-7.